In one paragraphArticle in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Zhikun WuMinistry of Education Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, School of Pharmaceutical Sciences, Wuhan University, Wuhan 430071, China.ORCID 0009-0005-1957-3540 Ziyue MengDepartment of Pharmaceutical Sciences, Northeastern University School of Pharmacy, Boston, MA 02115, USA.ORCID 0009-0008-8259-7117 Zhaoxiao YuInstitute of Microbiology, Academy of Agricultural Sciences of Xinjiang Uyghur Autonomous Region, Urumqi 830091, China.ORCID 0000-0003-4810-0580 Longtao CaoMinistry of Education Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, School of Pharmaceutical Sciences, Wuhan University, Wuhan 430071, China.
Jie WangMinistry of Education Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, School of Pharmaceutical Sciences, Wuhan University, Wuhan 430071, China.
Zhipeng XieMinistry of Education Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, School of Pharmaceutical Sciences, Wuhan University, Wuhan 430071, China.ORCID 0000-0001-6882-3300 Meng CuiDepartment of Pharmaceutical Sciences, Northeastern University School of Pharmacy, Boston, MA 02115, USA.ORCID 0000-0002-3895-135X Luyan Z MaState Key Laboratory of Microbial Diversity and Innovative Utilization, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China.ORCID 0000-0002-3837-6682 Feng LongMinistry of Education Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, School of Pharmaceutical Sciences, Wuhan University, Wuhan 430071, China.ORCID 0000-0001-6313-8558 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Resistance-nodulation-cell division (RND) efflux pumps are the major cause of multidrug resistance in
Indexed as
Bacterial ProteinsMembrane Transport ProteinsPseudomonas aeruginosaBacterial Outer Membrane ProteinsBinding SitesBiological TransportCryoelectron MicroscopyModels, MolecularMolecular Dynamics SimulationProtein BindingProtein ConformationTriclosanBacterial Outer Membrane ProteinsBacterial ProteinsMembrane Transport ProteinsTriclosan
Identifiers
PMID42566533
PMCPMC13450314
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390